Voluntary nationwide recall: Akorn Operating Company LLC

May 2023Important Notices
Akorn Operating Company LLC is initiating a voluntary recall of various within-expiry human and animal products. As a result of a bankruptcy, the firm is removing several products from the market due to the discontinuation of the Quality program, which would result in the company’s inability to assure that products meet the identity, strength, quality, and purity standards. Read the full text of the Akorn voluntary recall.

Recent Announcements

CME Webinar: The State of Telehealth in 2026

Please join us for a live, CME-accredited webinar on Tuesday, Jan. 27, from noon to 1 p.m. that will share updates on the state of telehealth for 2026.
Dec. 2025Education/Webinars

Formulary updates effective Jan. 1, 2026

Review upcoming policy and operational updates
Dec. 2025Pharmacy Updates

Voluntary nationwide recall: Famotidine (Fresenius – November)

Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.
Nov. 2025Pharmacy Updates